Carroll Financial Associates, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$6,0000.0%1020.0%0.00%
Q3 2021$6,000
-25.0%
1020.0%0.00%
Q2 2021$8,000
+33.3%
1020.0%0.00%
Q1 2021$6,000
-14.3%
1020.0%0.00%
Q4 2020$7,000
+75.0%
1020.0%0.00%
Q3 2020$4,000
+100.0%
102
+36.0%
0.00%
Q1 2020$2,000
+100.0%
75
+200.0%
0.00%
Q4 2019$1,000250.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders